Sort
48,018 grants matching “immunotherapy”
Immuno-Targeted Therapy for Melanoma
$899,241Antoni Ribas · University Of California Los Angeles · R35 · FY2018 · CA
Immuno-Targeted Therapy for Melanoma
$899,241Antoni Ribas · University Of California Los Angeles · R35 · FY2021 · CA
Immuno-Targeted Therapy for Melanoma
$899,241Antoni Ribas · University Of California Los Angeles · R35 · FY2017 · CA
Immuno-Targeted Therapy for Melanoma
$899,241Antoni Ribas · University Of California Los Angeles · R35 · FY2020 · CA
Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses
$899,116Emmett Vance Schmidt · Massachusetts General Hospital · U01 · FY2007 · AI
Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products
$898,913Xu Han · Cryocrate, Llc · R44 · FY2022 · CA
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$898,849James L Riley · University Of Pennsylvania · U19 · FY2024 · AI
Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses
$898,140Emmett Vance Schmidt · Massachusetts General Hospital · U01 · FY2008 · AI
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system
$897,777Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish
$897,391Leanna J Standish · Bastyr University · U19 · FY2011 · AT
Mechanisms of fibrosis in post-surgical lymphedema
$897,335Babak J Mehrara · Sloan-Kettering Inst Can Research · R01 · FY2019 · HL
Mechanisms of fibrosis in post-surgical lymphedema
$897,335Babak J Mehrara · Sloan-Kettering Inst Can Research · R01 · FY2021 · HL
Mechanisms of fibrosis in post-surgical lymphedema
$897,335Babak J Mehrara · Sloan-Kettering Inst Can Research · R01 · FY2020 · HL
Identification of Lethal Melanomas at the Time of Diagnosis
$897,329Nancy E Thomas · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION
$897,263University Of Michigan At Ann Arbor · U01 · FY2003 · DK
Identification of human tumor-associated antigens
$896,832Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
$896,700John F Dipersio · Washington University · R35 · FY2022 · CA
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
$896,519Mount Sinai Medical Center (Miami Beach) · U10 · FY2003 · CA
Overcoming pre-existing immunity to AAV to enhance AAV-based HIV immunotherapies
$896,461Mauricio De Aguiar Martins · University Of Florida · R01 · FY2023 · AI
Comprehensive antigenic mapping of the human anti-peanut IgE antibody response
$896,430Scott Alan Smith · Vanderbilt University Medical Center · R01 · FY2022 · AI
SPORE in Breast Cancer
$896,275Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2024 · CA
SPORE in Bladder Cancer
$896,275Jonathan Eric Rosenberg · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
NYU Melanoma SPORE
$896,274Iman Osman · New York University School Of Medicine · P50 · FY2024 · CA
Administrative Supplement: Interim Funding for Emory Lung Cancer SPORE
$896,274Suresh S Ramalingam · Emory University · P50 · FY2024 · CA
Tulane/LSU Pediatric AIDS Clinical Trials Unit
$895,978Tulane University Of Louisiana · U01 · FY2004 · AI